Evidence map›Paper›PMID 34430605›Full record

ArticleAnnals of translational medicine2021

Clinical impact of craniopharyngioma classification based on location origin: a multicenter retrospective study.

Wenfu Hu, Binghui Qiu, Fen Mei, Jian Mao, Lizhi Zhou, Fan Liu, Jun Fan, Yi Liu, Ge Wen, Songtao Qi and 2 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Update on management of craniopharyngiomas.Journal of neuro-oncology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Wenfu HuDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Binghui QiuDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fen MeiDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jian MaoDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Lizhi ZhouDepartment of Biostatistics, School of Biostatistics, Southern Medical University, Guangzhou, China.
Fan LiuDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jun FanDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yi LiuDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ge WenDepartment of Medical Imaging Center, Southern Medical University, Guangzhou, China.
Songtao QiDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yun BaoDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jun PanDepartment of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Southern Medical University · CNNanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn assessment of the clinical impact for craniopharyngiomas (CPs) classification based on origin location has not been reported. The aim of this study was to determine the clinical impact of the site of tumor origin in primary CPs.

methodsPatients from six national institutions who had undergone resection for primary CP were enrolled. Based on the point of origin and surrounding membranous structures, the location of the tumor origin was labelled as Q, S, or T, where Type Q CPs originated below the diaphragmatic area; Type S CPs originated from Rathke's pouch precursor cells; and Type T CPs originated from the Rathke's pouch precursor cells located above the pars tuberalis. Clinical characteristics, surgical approach, and outcome were evaluated according to the location of the tumor origin.

resultsAmong the 529 patients with primary CP, symptoms, age, histopathology type, tumor size, the incidence of hydrocephalus, survival rates, and recurrence-free survival rates were significantly different among tumors originating in different locations. Patients with type T CPs had higher symptom rates of intracranial hypertension and hypothalamic dysfunction, while those with type Q CPs had higher rates of hormone deficits during pre-and post-operative management. Type S CPs were correlated with better outcomes and lower recurrence rates. The location of origin and primary therapy with survival and recurrence in CP were independent factors for survival and recurrence in multivariate analysis.

conclusionsThe identification of the different location of origin of CPs is of great significance in understanding the relationship between tumors and peripheral tissues. The origin of tumors effects the choice of surgical approach and prognosis.

Indexed as

classificationCraniopharyngioma (CP)origin locationoutcome

Identifiers

PMID34430605
PMCPMC8350632
OpenAlexW3181696128

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.